Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02855060 · ClinicalTrials.gov registry record · NA

Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT02855060 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02855060, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether the use of pelvic binders in the ambulance setting improves outcomes including mortality in patients with pelvic fractures.

Interventions

  • DEVICE Pelvic Binder

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2016-07
Est. Completion 2018-12
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT02855060

The ClinicalTrials.gov registry entry for NCT02855060 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Pelvic Binder is the first listed.

NCT02855060 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02855060 about?

NCT02855060 is a clinical study titled "Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis". The purpose of this study is to determine whether the use of pelvic binders in the ambulance setting improves outcomes including mortality in patients with pelvic fractures.

What is the current status of trial NCT02855060?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-07. Estimated completion is 2018-12.

What interventions are being tested in trial NCT02855060?

The interventions under investigation include: Pelvic Binder (DEVICE).

Who is sponsoring clinical trial NCT02855060?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.